Maekawa Yuichiro, Ikeda Yuika, Torigoe Makio, Shimoura Kanako, Suo Shintaro, Takeda Ryohei, Kitaoka Hiroaki
Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Health Economics and Outcomes Research, Bristol Myers Squibb, Tokyo, Japan.
Future Cardiol. 2025 Aug;21(10):759-768. doi: 10.1080/14796678.2025.2526279. Epub 2025 Jul 11.
To identify factors affecting the health-related quality of life (HR-QOL) of symptomatic patients with hypertrophic cardiomyopathy (HCM) using qualitative interviews exploring patients' experiences and perceptions.
PATIENTS & METHODS: This cross-sectional observational study was conducted using qualitative web-based or telephone interviews. Adult patients with HCM in Japan who were experiencing burden because of HCM were included. In-depth interviews were conducted using a semi-structured interview guide. The data were analyzed using a thematic analysis approach.
Nineteen patients completed the interview. Ten HR-QOL-related themes were identified. Many patients were unaware that they had HCM symptoms, either no longer noticing them following life adjustments or attributing them to factors other than HCM. HCM affected multiple life aspects, including work, family, and social life. Patients resisted disclosing their disease to others and strongly resisted invasive treatment. Patients highly trusted their physicians but were reluctant to discuss their mental burdens and daily life challenges with them.
This first qualitative study of HR-QOL in patients with HCM in Japan suggests that deeper physician - patient communication is needed to understand patient burden and needs, as patients have difficulty discussing their burdens with physicians and may lack awareness of HCM symptoms.
NCT06181617 (ClinicalTrials.gov).
通过定性访谈探索患者的经历和认知,以确定影响症状性肥厚型心肌病(HCM)患者健康相关生活质量(HR-QOL)的因素。
本横断面观察性研究采用基于网络或电话的定性访谈进行。纳入了日本因HCM而承受负担的成年HCM患者。使用半结构化访谈指南进行深入访谈。采用主题分析方法对数据进行分析。
19名患者完成了访谈。确定了10个与HR-QOL相关的主题。许多患者未意识到自己有HCM症状,要么在生活调整后不再注意到这些症状,要么将其归因于HCM以外的因素。HCM影响多个生活方面,包括工作、家庭和社交生活。患者拒绝向他人透露自己的病情,强烈抵制侵入性治疗。患者高度信任他们的医生,但不愿与医生讨论他们的心理负担和日常生活挑战。
这项针对日本HCM患者HR-QOL的首次定性研究表明,由于患者难以与医生讨论他们的负担,且可能缺乏对HCM症状的认识,因此需要更深入的医患沟通来了解患者的负担和需求。
NCT06181617(ClinicalTrials.gov)。